AlphAIAlphAI — Financial news for AI agents
investing.comSEP 112 min read$EL

Estee Lauder (EL) stock analysis: Is the latest dip a buying opportunity?

Estee Lauder (EL) stock fell 7.12% in a week, closing at $96.47. Deutsche Bank sees potential for $120-$130 in 12-18 months. Technicals show mixed signals: daily sell, weekly strong buy, monthly neutral. Bull case cites EPS beats and revenue growth, while bear case highlights high valuation and debt. Next earnings on Nov 2, 2026.

Original reporting
investing.com
Published Sep 11, 2026, 11:54 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 12:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefMarket movers
Primary signal
$EL
Neutral
medium confidence
Mentioned
$EL
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ELNeutralLow
01

Why it matters

No new fundamental data; the article provides a trading view based on price levels and upcoming earnings.

02

Market read

Primarily relevant to traders tracking EL; limited broader market impact.

03

What to watch

Potential impact of upcoming earnings on Nov 2 and any China‑related demand shifts are not quantified.

Relevance 4/10Novelty 2/10Timing: pre‑market today

Background

The piece is a chart‑driven technical analysis of Estee Lauder (EL) following a recent price decline.

Company-level read

Ticker impact

$ELNeutralMedium confidence
Context

EL fell 7.12% over the week to $96.47; chart analysis highlights support at $95.78‑$96.83 and a potential bounce above $99.09.

Expected impact

Possible short‑term upside to $99.09; downside risk to $94.00 if support fails.

Evidence & confidence

Technical levels are clear; no new fundamental catalyst was disclosed.

Market effects

Sector

Beauty and personal care sector may see modest attention as EL's price action could influence peer sentiment.

Regional

Limited to US and European consumer discretionary markets.

Global

Low; the article focuses on a single stock without broader macro implications.

Counterpoint

What could challenge this read

If the market over‑reacts to the pullback, EL could continue sliding below $95, offering a deeper entry point.

Key entities

  • company
    Estee Lauder Companies Inc.

    US‑listed beauty and cosmetics conglomerate (ticker EL).

Read at source← All news

Related articles

SEP 15
$ELMed

Estee Lauder outlook revised to stable by S&P on deleveraging

S&P Global Ratings revised Estee Lauder's outlook to stable from negative, citing improved operating results and credit metrics. The agency expects adjusted leverage to fall to 1.9x by fiscal 2027, with mid-single-digit revenue growth and expanded EBITDA margins. Cash flows are projected to decline due to restructuring and investments, but the company plans to use cash balances for debt repayment.

investing.com2 min
AUG 28
$ELHighAI 8/10

Estée Lauder (EL)’s China Bet Just Paid Off. Its Makeup Business Still Hasn’t Caught Up

Estée Lauder (EL) reported Q4 net sales of $3.63B, up 6.3%, driven by luxury fragrance and skincare. It forecasted fiscal 2027 adjusted EPS of $3.10-$3.35, above estimates, sending shares up 11% premarket. However, makeup sales were flat, and hair care dropped 1%. The company also reported a $38M tariff-refund benefit and a net loss of $116M, down from $546M a year earlier.

yahoo.com2 min
AUG 28
$ELMedAI 8/10

Estee Lauder vs Nike: One Turnaround Just Proved Itself, the Other Keeps Slipping

Estee Lauder (EL) reported four consecutive earnings beats, raising its fiscal 2027 EPS guidance to $3.10-$3.35. Nike (NKE) guided revenue down, with Greater China down 12% and Converse down 32%. EL's stock rose 10.46% post-earnings, while NKE's turnaround timeline extends. EL's forward P/E is near 32, with a 1.3% yield. NKE offers a 4.3% yield but faces declining revenue.

aol.com3 min
AUG 27
$MRNAHighAI 8/10

3 Stocks Soared, 3 Stocks Slumped

Moderna (MRNA) surged 176.97% to $174.38 after reporting positive trial results for a cancer therapy with Merck (MRK). Estee Lauder (EL) rose 16% to $98.01 with revenue up 6.5% Y/Y. MicroStrategy (MSTR) gained 12.68% as Bitcoin prices rose. Nebius (NBIS) fell 10% after a $4.5B convertible note offering. Seagate (STX) dropped 8% to $832.56.

baystreet.ca2 min
AUG 27
$ELHighAI 8/10

Estée Lauder’s (EL) Turnaround Story Just Got Real Numbers Behind It

Estée Lauder (EL) reported fiscal 2026 Q4 and full-year earnings, showing organic net sales up 3%, adjusted operating margin at 11.2%, and adjusted diluted EPS at $2.51. Fragrance and Skin Care led growth, with Jo Malone and TOM FORD joining the billion-dollar brand club. The company guided fiscal 2027 organic sales growth of 3% to 5% and adjusted operating margin of 12.7% to 13.5%. Challenges include Middle East conflict impacts and Hair Care declines. Hedge fund ownership held steady at 47 fun

insidermonkey.com3 min
AUG 26
$ELHighAI 9/10

Estée Lauder (EL) Q4 2026 Earnings Call Transcript

Estée Lauder (EL) reported 3% organic net sales growth for fiscal 2026, with adjusted EPS of $2.51, up 66%. Key drivers included 10% fragrance sales growth and 9% growth in Mainland China. Guidance for fiscal 2027 includes 3-5% organic sales growth and adjusted EPS of $3.10-$3.35. Management highlighted margin expansion and strategic initiatives, including headcount reductions and digital investments.

aol.com3 min